Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium in COVID-19
NCT04869579Phase 2Unknown
- Sponsor
- CHRISTUS Health
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selenious acid in coronavirus disease 2019 (COVID-19), sponsored by CHRISTUS Health. Status: unknown.
02
Drugs
selenious acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04869579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04869579.